Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-035392

Chief Dev. & Ops. Officer bought 420 shares at $11.99 ($5,036)

From the SEC's structured data for this filing

Trades in this filing

Shemesh Shay · Chief Dev. & Ops. Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-21 Purchase : show line 1 in the form +420 $11.99 $5,036 1,361,955 D
Open-market purchases · 420 sh · avg $11.99 · $5,036
Loading xslF345X04/tm2310219d1_4seq1.xml…